NCT06214832

Brief Summary

This study identify prescription patterns of Lodient Tab and evaluate the changes of the hypertension symptoms (BP pressure) who are first prescribed and taking Lodient Tab.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
4,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 11, 2021

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

January 3, 2024

Completed
19 days until next milestone

First Posted

Study publicly available on registry

January 22, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2025

Completed
Last Updated

January 22, 2024

Status Verified

January 1, 2024

Enrollment Period

3.1 years

First QC Date

January 3, 2024

Last Update Submit

January 17, 2024

Conditions

Hypertension

Outcome Measures

Primary Outcomes (1)

  • The percentage of patients who met target systolic blood pressure (less than 140mmHg) at 6 months of prescription for Lodient Tab compared to baseline

    The percentage of patients who met target systolic blood pressure (less than 140mmHg) at 6 months of prescription for Lodient Tab compared to baseline

    at 6 months of prescription for Lodient Tab compared to baseline

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients Prescribed Lodient Tab for Hypertension Treatment

You may qualify if:

  • Adults over 19 years of age
  • A person diagnosed with hypertension
  • A person who has been first prescribed Lodient Tab within the past 4 months as of the IRB approval date or is scheduled to be prescribed Lodient Tab
  • A person who voluntarily agreed in writing to this study

You may not qualify if:

  • Pregnant women or nursing mothers
  • Persons subject to prohibition according to the permission of the Lodient Tab
  • Patients who in the judgement of the investigator, were inappropriate to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul song clinic

Seoul, South Korea

RECRUITING

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Officials

  • Minseob Song

    Seoul song clinic

    STUDY CHAIR

Central Study Contacts

Minseob Song

CONTACT

+820222737282song2you@naver.com

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 3, 2024

First Posted

January 22, 2024

Study Start

November 11, 2021

Primary Completion

December 30, 2024

Study Completion

August 30, 2025

Last Updated

January 22, 2024

Record last verified: 2024-01

Locations

KR(1)